Asia Pacific Blood Collection Devices Market (2025-2030)
The Asia Pacific Blood Collection Devices Market was valued at $957.4 Million in 2025 and projected to reach to $1530.8 Million by 2030, representing a compound annual growth rate of 9.8%. The Asia Pacific blood collection devices market is positioned for substantial growth, expanding from $957.4 million in 2025 to $1,530.8 million by 2030.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Blood Collection Devices Market Trends and Insights
- Asia Pacific's market expansion is driven by rising healthcare infrastructure investments, increasing diagnostic testing demand, and growing awareness of blood safety protocols across the region.
- The 9.8% compound annual growth rate reflects Asia Pacific's accelerating adoption of advanced phlebotomy technologies and standardized collection procedures. Asia Pacific's blood collection devices sector benefits from a large patient population, expanding hospital networks, and government initiatives promoting preventive healthcare.
- Between 2025 and 2030, Asia Pacific is expected to see significant penetration of safety-engineered devices and automated collection systems.
- The region's market growth outpaces the global average, positioning Asia Pacific as a critical growth engine for blood collection device manufacturers and healthcare providers..
Key Market Statistics
- CAGR (2025-2030) 9.8% CAGR
- Market Size, 2025 ~USD 957.4 Million
- Forecast, 2030 ~USD 1530.8 Million
- Geography Asia Pacific
Asia Pacific Blood Collection Devices Market Overview
Rapid Market Expansion :
Asia Pacific blood collection devices market is growing at 9.8% CAGR, significantly outpacing the global rate of 7.4%, driven by increasing healthcare investments across emerging economies.
Infrastructure Development :
Rising healthcare infrastructure investments in countries like China and India are creating robust demand for advanced blood collection technologies and diagnostic testing capabilities.
Safety Protocol Adoption :
Growing awareness of blood safety protocols and infection control measures across Asia Pacific is accelerating adoption of modern blood collection devices in hospitals and diagnostic centers.
Diagnostic Testing Surge :
Increasing demand for diagnostic testing, driven by rising disease prevalence and preventive healthcare initiatives, is fueling the need for reliable blood collection solutions throughout the region.
Asia Pacific Blood Collection Devices Market Dynamics
- This 9.8% CAGR reflects the region's accelerating healthcare modernization and increased investment in diagnostic infrastructure.
- Key growth drivers include rising healthcare expenditure, expanding hospital networks, and growing emphasis on blood safety standards across emerging markets. Countries like China, India, and Japan are leading market expansion through government healthcare initiatives and private sector investments.
- The region's large population base, combined with improving healthcare access and rising awareness of preventive diagnostics, creates sustained demand for blood collection devices.
- Strategic partnerships and localized manufacturing are expected to further enhance market penetration and accessibility across Asia Pacific..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Asia Pacific blood collection devices market valued at $957.4M in 2025, growing to $1,530.8M by 2030 at 9.8% CAGR
- Asia Pacific's growth rate exceeds global average, driven by expanding healthcare infrastructure and diagnostic demand
- Safety-engineered and automated collection devices are gaining adoption across Asia Pacific healthcare facilities
- Asia Pacific's large population and government healthcare initiatives position the region as a key growth market through 2030
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Asia Pacific Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
Target Audience
- Medical Device Manufacturers : Manufacturers need Asia Pacific market intelligence to develop region-specific product strategies, identify distribution partnerships, and capitalize on the 9.8% growth opportunity in emerging markets.
- Healthcare Facility Operators : Hospital networks and diagnostic centers require market data to optimize procurement strategies, evaluate supplier options, and align blood collection device investments with regional standards.
- Investment & Private Equity Firms : Investors need detailed market forecasts and country-level data to evaluate acquisition targets, assess portfolio company growth potential, and identify high-growth segments in Asia Pacific healthcare.
- Healthcare Consultants : Consulting firms require comprehensive regional analysis to advise clients on market entry strategies, competitive positioning, and operational optimization in Asia Pacific blood collection markets.
- Government & Policy Makers : Healthcare policymakers need market insights to inform healthcare infrastructure planning, procurement policies, and regulatory frameworks supporting blood safety and diagnostic capabilities.
Key Companies in the Asia Pacific Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 450.5 Million |
| India | USD 325.5 Million |
| Japan | USD 428.8 Million |
| Australia | USD 113 Million |
| Rest Of Asia Pacific | USD 213 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Growth Opportunity : Capture insights into the fastest-growing blood collection devices market segment with 9.8% CAGR, significantly outpacing global growth and offering substantial expansion opportunities.
- Country-Specific Market Data : Access detailed market sizing and forecasts for key Asia Pacific markets including China, India, Japan, and Australia to inform localized business strategies and investment decisions.
- Infrastructure Investment Trends : Understand healthcare infrastructure development patterns across Asia Pacific to identify emerging opportunities in diagnostic centers, hospitals, and blood banks requiring modern collection devices.
- Competitive Landscape Analysis : Gain strategic intelligence on regional competitors, market consolidation trends, and partnership opportunities specific to Asia Pacific's unique regulatory and operational environment.
- Demand Drivers & Forecasting : Leverage comprehensive analysis of diagnostic testing demand, safety protocol adoption, and population health trends to forecast market dynamics through 2030 with precision.
Frequently asked questions
What is the current size of the Asia Pacific blood collection devices market?
The Asia Pacific blood collection devices market is valued at $957.4 million in 2025 and is projected to reach $1,530.8 million by 2030.
What is the expected growth rate for Asia Pacific blood collection devices?
Asia Pacific blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2030.
What factors are driving growth in the Asia Pacific blood collection devices market?
Key drivers include expanding healthcare infrastructure, rising diagnostic testing demand, government healthcare initiatives, and increasing adoption of safety-engineered collection devices across Asia Pacific.
How does Asia Pacific's growth compare to the global market?
Asia Pacific's 9.8% CAGR outpaces the global average of 7.4%, making the region a high-growth market for blood collection devices.
Which product types are gaining traction in Asia Pacific?
Safety-engineered devices, automated collection systems, and standardized phlebotomy technologies are experiencing increased adoption across Asia Pacific healthcare facilities.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
